# Nanjing F&S Pharmatech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanjing-f-s-pharmatech-co

- Industry: Pharmaceuticals
- Headquarters: Nanjing, China
- Website: www.fshpharm.com
- Total disclosed funding: $16M
- Latest round: Series B (Mar 20, 2020)
- Investors on record: 8

## About

Based in Nanjing, China and established in 2015, Nanjing F&S Pharmatech Co., Ltd. is a developer and manufacturer of differentiated API, KSM and pharmaceutical intermediates based on chemical technology.

## Funding rounds

- Series B, Mar 20, 2020, $8.9M — Kaitai Capital, Guosheng Securities, Zhengxinhe Investment, BGI Co-WIN Investment Management, Jinyuan Capital
- Series A, Sep 30, 2018, $7.3M — Kaitai Capital, Shenzhen Huada Gene Technology Co., Ltd., Dynamic Capital
- Series A, May 3, 2018 — CGP Investment

## Investors

- CGP Investment — Series A
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series A, Series B
- Shenzhen Huada Gene Technology Co., Ltd. — Series A
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series A
- Guosheng Securities — Series B
- Zhengxinhe Investment — Series B
- BGI Co-WIN Investment Management (https://capitalatlas.ai/funds/bgi-co-win-investment-management) — Series B
- Jinyuan Capital (https://capitalatlas.ai/funds/jinyuan-capital) — Series B